| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |